Skip to main content

Gupta Ashoo's Form 4 filing

4D Molecular Therapeutics, Inc. (FDMT) · filed Dec 23, 2025

Accession no.
0001193125-25-331299
Filed
Dec 23, 2025
Trade date
Dec 20, 2025
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.38K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gupta AshooCIK 0002091461Officer (VP, Finance and Controller)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 20, 2025Common StockMOption exerciseAcquired+866–F1–46,528Direct
Dec 20, 2025Common StockSSaleDisposed−310$8.68−$2,690.846,218Direct
Dec 20, 2025Common StockMOption exerciseAcquired+220–F1–46,438Direct
Dec 20, 2025Common StockSSaleDisposed−79$8.68−$685.7246,359Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 20, 2025Common StockMOption exerciseDisposed−866$0.00$012,984Direct
Dec 20, 2025Common StockMOption exerciseDisposed−220$0.00$03,308Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted Stock Units convert into common stock on a one-for-one basis.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)